PremiumRatingsDefinitive Healthcare Corp: Hold Rating Amid Positive Developments and Market Challenges Definitive Healthcare Reports Q1 2025 Financial Results Definitive Healthcare sees Q2 EPS 4c-5c, consensus 5c PremiumThe FlyDefinitive Healthcare price target lowered to $3 from $4 at Barclays Dell reports mixed Q4 results, Intel delays Ohio chip factory: Morning Buzz Definitive Healthcare Corp: Hold Rating Amid Retention Challenges and Strategic Opportunities PremiumThe FlyDefinitive Healthcare reports Q4 adjusted EPS 8c, consensus 7c Definitive Healthcare sees Q1 adjusted EPS 2c, consensus 7c Definitive Healthcare downgraded to Underweight from Equal Weight at Barclays